Coapt, Chicago, is celebrating ten years in O&P. Coapt was founded in 2012 and launched Complete Control, the first US Food and Drug Administration Class II-cleared myoelectric, machine-learning prosthesis control system. The flagship product is now in its second generation.
“Ten years ago the benefits of our technology were being asked for and the efforts of transitioning it from the research lab to clinical reality were undertaken” said Blair Lock, CEO of Coapt. “Since then, Coapt has continued to grow and innovate under our vision of ‘creating human machine interfaces that benefit humans.’”
Coapt’s products are available in the United States, Canada, Australia, New Zealand, and much of Europe.
